Biochemistry and molecular cell biology of diabetic complications
The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Abstract
Diabetes-specific microvascular disease is a leading cause of blindness, renal failure and nerve damage, and diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke and limb amputation. Four main molecular mechanisms have been implicated in glucose-mediated vascular damage. All seem to reflect a single hyperglycaemia-induced process of overproduction of superoxide by the mitochondrial electron-transport chain. This integrating paradigm provides a new conceptual framework for future research and drug discovery.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although treatments are available, diabetes remains a leading cause of blindness, end-stage renal disease, lower limb amputation and cardiovascular disease.40”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [40]
In the citing paper
“Second, high cellular ROS levels are associated with cancer, diabetes, inflammatory diseases, ischemia-related diseases, and neurodegeneration, and are thus commonly thought to contribute to human pathologies and aging 80–83.”
From Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes (2010) · cites this paper as [82]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · cited 1×
“This issue has now been resolved by the recent discovery that each of the four different pathogenic mechanisms reflects a single hyperglycaemia-induced process: overproduction of superoxide by the mitochondrial electron-transport chai”
Self-citationAngiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
(2000) · PubMed · Cited by 2,095
Research works printed but not linked: 1
- Koya, D. et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest. 100, 115–126 (1997). · DOI · Paper page
Cited by
Items 201–300 of 1,108
Vanhorebeek, I., De Vos, R., Mesotten, D., Wouters, P. J., De Wolf-Peeters, C., & Van den Berghe, G. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17665-4 · Cited by 452
Witte, A. V., Kerti, L., Margulies, D. S., & Floel, A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0385-14.2014 · Cited by 455
Nutrients and Oxidative Stress: Friend or Foe?
Tan, B. L., Norhaizan, M. E., & Liew, W.-P.-P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/9719584 · Cited by 403
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome
Ruderman, N., & Prentki, M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1344 · Cited by 451
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 424
Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential
Becker, B. F., Chappell, D., Bruegger, D., Annecke, T., & Jacob, M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq137 · Cited by 438
Endothelial Glycocalyx Damage Coincides With Microalbuminuria in Type 1 Diabetes
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A. E., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B. L., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1619 · Cited by 442
Ganesh Yerra, V., Negi, G., Sharma, S. S., & Kumar, A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.005 · Cited by 412
The Role of Oxidative Stress in the Pathophysiology of Gestational Diabetes Mellitus
Lappas, M., Hiden, U., Desoye, G., Froehlich, J., Mouzon, S. H.-D., & Jawerbaum, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3765 · Cited by 442
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Wautier, J.-L., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 436
ZACHARA, N. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.016 · Cited by 426
Hassa, P. O., & Hottiger, M. O. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8527-2 · Cited by 427
Genetics and the Specificity of the Aging Process
Hekimi, S., & Guarente, L. (2003) · Science · doi:10.1126/science.1082358 · Cited by 434
Geraldes, P., Hiraoka-Yamamoto, J., Matsumoto, M., Clermont, A., Leitges, M., Marette, A., Aiello, L. P., Kern, T. S., & King, G. L. (2009) · Nature Medicine · doi:10.1038/nm.2052 · Cited by 425
Diabetic Retinopathy: Vascular and Inflammatory Disease
Semeraro, F., Cancarini, A., dell’Omo, R., Rezzola, S., Romano, M. R., & Costagliola, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/582060 · Cited by 424
Diacylglycerol kinases: at the hub of cell signalling
Mérida, I., Ávila-Flores, A., & Merino, E. (2008) · Biochemical Journal · doi:10.1042/bj20071040 · Cited by 427
URIBARRI, J., CAI, W., SANDU, O., PEPPA, M., GOLDBERG, T., & VLASSARA, H. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.052 · Cited by 423
Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.029 · Cited by 407
Nakamura, S., Takamura, T., Matsuzawa-Nagata, N., Takayama, H., Misu, H., Noda, H., Nabemoto, S., Kurita, S., Ota, T., Ando, H., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901488200 · Cited by 426
Hyperglycemia and Glycation in Diabetic Complications
Negre-Salvayre, A., Salvayre, R., Augé, N., Pamplona, R., & Portero-Otín, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2484 · Cited by 421
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
Yan, L.-J. (2014) · Journal of Diabetes Research · doi:10.1155/2014/137919 · Cited by 397
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Iavicoli, I., Di Paola, R., Koverech, A., Cuzzocrea, S., Rizzarelli, E., & Calabrese, E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.002 · Cited by 420
Diabetic Cardiovascular Disease Induced by Oxidative Stress
Kayama, Y., Raaz, U., Jagger, A., Adam, M., Schellinger, I., Sakamoto, M., Suzuki, H., Toyama, K., Spin, J., & Tsao, P. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161025234 · Cited by 407
Oxidative Stress, Chronic Disease, and Muscle Wasting
Moylan, J. S., & Reid, M. B. (2007) · Muscle & Nerve · doi:10.1002/mus.20743 · Cited by 416
Sekhar, R. V., McKay, S. V., Patel, S. G., Guthikonda, A. P., Reddy, V. T., Balasubramanyam, A., & Jahoor, F. (2011) · Diabetes Care · doi:10.2337/dc10-1006 · Cited by 399
Diabetic peripheral neuropathy: Current perspective and future directions
Singh, R., Kishore, L., & Kaur, N. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.12.005 · Cited by 400
Nitric oxide: a newly discovered function on wound healing
LUO, J.-D., & CHEN, A. F. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00058.x · Cited by 410
Villeneuve, L. M., Reddy, M. A., Lanting, L. L., Wang, M., Meng, L., & Natarajan, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803623105 · Cited by 412
Broekhuizen, L. N., Lemkes, B. A., Mooij, H. L., Meuwese, M. C., Verberne, H., Holleman, F., Schlingemann, R. O., Nieuwdorp, M., Stroes, E. S. G., & Vink, H. (2010) · Diabetologia · doi:10.1007/s00125-010-1910-x · Cited by 406
Glucose Variability; Does It Matter?
Siegelaar, S. E., Holleman, F., Hoekstra, J. B. L., & DeVries, J. H. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0021 · Cited by 409
Should minimal blood glucose variability become the gold standard of glycemic control?
Hirsch, I. B., & Brownlee, M. (2005) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.10.001 · Cited by 405
Self-citationControlling cell–cell interactions using surface acoustic waves
Guo, F., Li, P., French, J. B., Mao, Z., Zhao, H., Li, S., Nama, N., Fick, J. R., Benkovic, S. J., & Huang, T. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422068112 · Cited by 406
Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction
Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19774 · Cited by 394
Jung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Yamagishi, S.-I., & Matsui, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11148 · Cited by 397
The proximal tubule in the pathophysiology of the diabetic kidney
Vallon, V. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00809.2010 · Cited by 395
(Pre)diabetes, brain aging, and cognition
S. Roriz-Filho, J., Sá-Roriz, T. M., Rosset, I., Camozzato, A. L., Santos, A. C., Chaves, M. L. F., Moriguti, J. C., & Roriz-Cruz, M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.12.003 · Cited by 386
An immune origin of type 2 diabetes?
Kolb, H., & Mandrup-Poulsen, T. (2005) · Diabetologia · doi:10.1007/s00125-005-1764-9 · Cited by 394
Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease
MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.048 · Cited by 378
Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management
Kruyt, N. D., Biessels, G. J., DeVries, J. H., & Roos, Y. B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.231 · Cited by 386
Sandireddy, R., Yerra, V. G., Areti, A., Komirishetty, P., & Kumar, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/674987 · Cited by 364
Hyperglycemia Regulates Hypoxia-Inducible Factor-1α Protein Stability and Function
Catrina, S.-B., Okamoto, K., Pereira, T., Brismar, K., & Poellinger, L. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3226 · Cited by 384
Li, D., Zhang, Y., Liu, Y., Sun, R., & Xia, M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.205674 · Cited by 372
Nishikawa, T., & Araki, E. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.1458 · Cited by 391
Oxidative Stress in Health and Disease
Reddy, V. P. (2023) · Biomedicines · doi:10.3390/biomedicines11112925 · Cited by 333
Proposed mechanisms for the induction of insulin resistance by oxidative stress
Bloch-Damti, A., & Bashan, N. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1553 · Cited by 388
Palsamy, P., & Subramanian, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.008 · Cited by 380
The cardio-renal-metabolic connection: a review of the evidence
Marassi, M., & Fadini, G. P. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01937-x · Cited by 386
Isermann, B., Vinnikov, I. A., Madhusudhan, T., Herzog, S., Kashif, M., Blautzik, J., Corat, M. A. F., Zeier, M., Blessing, E., Oh, J., et al. (2007) · Nature Medicine · doi:10.1038/nm1667 · Cited by 385
Dietary Advanced Glycation End Products and Their Role in Health and Disease
Uribarri, J., del Castillo, M. D., de la Maza, M. P., Filip, R., Gugliucci, A., Luevano-Contreras, C., Macías-Cervantes, M. H., Markowicz Bastos, D. H., Medrano, A., Menini, T., et al. (2015) · Advances in Nutrition · doi:10.3945/an.115.008433 · Cited by 369
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
Sebastian, S. A., Padda, I., & Johal, G. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102344 · Cited by 343
Oxidative stress and calcium dysregulation by palmitate in type 2 diabetes
Ly, L. D., Xu, S., Choi, S.-K., Ha, C.-M., Thoudam, T., Cha, S.-K., Wiederkehr, A., Wollheim, C. B., Lee, I.-K., & Park, K.-S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.157 · Cited by 378
Diabetic Neuropathy: Mechanisms, Emerging Treatments, and Subtypes
Albers, J. W., & Pop-Busui, R. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0473-5 · Cited by 357
Lipid Peroxidation in Diabetes Mellitus
Davì, G., Falco, A., & Patrono, C. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.256 · Cited by 376
Vallon, V., & Thomson, S. C. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153333 · Cited by 376
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Federici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti, G., & Lauro, R. (2002) · Circulation · doi:10.1161/01.cir.0000023043.02648.51 · Cited by 373
van Dijk, H. W., Kok, P. H. B., Garvin, M., Sonka, M., DeVries, J. H., Michels, R. P. J., van Velthoven, M. E. J., Schlingemann, R. O., Verbraak, F. D., & Abra`moff, M. D. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-3143 · Cited by 367
Neutrophil function and metabolism in individuals with diabetes mellitus
Alba-Loureiro, T. C., Munhoz, C. D., Martins, J. O., Cerchiaro, G. A., Scavone, C., Curi, R., & Sannomiya, P. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006005000143 · Cited by 371
Prevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., & Thornalley, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2110 · Cited by 373
Schulze, P. C., Yoshioka, J., Takahashi, T., He, Z., King, G. L., & Lee, R. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400549200 · Cited by 369
Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
Zhu, J., Hu, Z., Luo, Y., Liu, Y., Luo, W., Du, X., Luo, Z., Hu, J., & Peng, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265372 · Cited by 310
Microvascular complications of impaired glucose tolerance
Singleton, J. R., Smith, A. G., Russell, J. W., & Feldman, E. L. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2867 · Cited by 372
Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy
Long, J., Badal, S. S., Ye, Z., Wang, Y., Ayanga, B. A., Galvan, D. L., Green, N. H., Chang, B. H., Overbeek, P. A., & Danesh, F. R. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87927 · Cited by 372
Aging, obesity, and inflammatory age-related diseases
Frasca, D., Blomberg, B. B., & Paganelli, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01745 · Cited by 371
AGE, RAGE, and ROS in Diabetic Nephropathy
Tan, A. L. Y., Forbes, J. M., & Cooper, M. E. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.006 · Cited by 368
Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370
Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 371
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
Hyperglycemia and the Pathobiology of Diabetic Complications
Aronson, D. (2008) · Advances In Cardiology · doi:10.1159/000115118 · Cited by 362
Pasquel, F. J., & Umpierrez, G. E. (2014) · Diabetes Care · doi:10.2337/dc14-0984 · Cited by 345
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution
Niemann, B., Rohrbach, S., Miller, M. R., Newby, D. E., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.043 · Cited by 353
Postprandial Glucose Regulation and Diabetic Complications
Ceriello, A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2090 · Cited by 362
Perraud, A.-L., Takanishi, C. L., Shen, B., Kang, S., Smith, M. K., Schmitz, C., Knowles, H. M., Ferraris, D., Li, W., Zhang, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411446200 · Cited by 358
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
Bouché, C., Serdy, S., Kahn, C. R., & Goldfine, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0026 · Cited by 346
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
Satchell, S. C., & Tooke, J. E. (2008) · Diabetologia · doi:10.1007/s00125-008-0961-8 · Cited by 361
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Xu, J., & Zou, M.-H. (2009) · Circulation · doi:10.1161/circulationaha.108.835223 · Cited by 353
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
Bakker, W., Eringa, E. C., Sipkema, P., & van Hinsbergh, V. W. M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0685-6 · Cited by 343
Mitochondria, endothelial cell function, and vascular diseases
Tang, X., Luo, Y.-X., Chen, H.-Z., & Liu, D.-P. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00175 · Cited by 345
Ramalho-Santos, J., Amaral, S., & Oliveira, P. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502398 · Cited by 359
Janaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00423-2 · Cited by 358
“and free fatty acids increase mitochondrial superoxide production [78].”
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 348
Wintergerst, K. A., Buckingham, B., Gandrud, L., Wong, B. J., Kache, S., & Wilson, D. M. (2006) · Pediatrics · doi:10.1542/peds.2005-1819 · Cited by 360
Sterling, P. (2004) · Allostasis, Homeostasis, and the Costs of Physiological Adaptation · doi:10.1017/cbo9781316257081.004 · Cited by 353
Oxidative stress in early diabetic nephropathy: fueling the fire
Singh, D. K., Winocour, P., & Farrington, K. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.212 · Cited by 353
Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases
Vona, R., Gambardella, L., Cittadini, C., Straface, E., & Pietraforte, D. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8267234 · Cited by 331
Metabolic stress–induced activation of FoxO1 triggers diabetic cardiomyopathy in mice
Battiprolu, P. K., Hojayev, B., Jiang, N., Wang, Z. V., Luo, X., Iglewski, M., Shelton, J. M., Gerard, R. D., Rothermel, B. A., Gillette, T. G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60329 · Cited by 345
The transient receptor potential channel TRPA1: from gene to pathophysiology
Nilius, B., Appendino, G., & Owsianik, G. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1158-z · Cited by 335
Role of Advanced Glycation End Products in Diabetic Nephropathy
Forbes, J. M., Cooper, M. E., Oldfield, M. D., & Thomas, M. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077413.41276.17 · Cited by 351
Du, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Self-citationHjelmesæth, J., Hartmann, A., Leivestad, T., Holdaas, H., Sagedal, S., Olstad, M., & Jenssen, T. (2006) · Kidney International · doi:10.1038/sj.ki.5000116 · Cited by 345
Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells
Ungvari, Z., Labinskyy, N., Mukhopadhyay, P., Pinto, J. T., Bagi, Z., Ballabh, P., Zhang, C., Pacher, P., & Csiszar, A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00375.2009 · Cited by 341
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347
Angiopoietin-2 Causes Pericyte Dropout in the Normal Retina
Hammes, H.-P., Lin, J., Wagner, P., Feng, Y., vom Hagen, F., Krzizok, T., Renner, O., Breier, G., Brownlee, M., & Deutsch, U. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1104 · Cited by 342
Self-citationThallas-Bonke, V., Thorpe, S. R., Coughlan, M. T., Fukami, K., Yap, F. Y. T., Sourris, K. C., Penfold, S. A., Bach, L. A., Cooper, M. E., & Forbes, J. M. (2008) · Diabetes · doi:10.2337/db07-1119 · Cited by 345
Advanced glycation end-products and the progress of diabetic vascular complications.
Jakuš, V, & Rietbrock, N. (2004) · Physiological Research · doi:10.33549/physiolres.930430 · Cited by 341
The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
Metadata
- Authors
- Brownlee, M.
- Affiliations
- Albert Einstein College of Medicine (US)
- Corresponding author
- Brownlee, Michael
- Venue
- Nature
- Published
- 2001-12-13
- Volume
- 414
- Issue
- 6865
- Pages
- 813-820
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2044437167
- Cited by
- 9,107
- References
- 170
- Citations by year
- 2026: 264 · 2025: 264 · 2024: 292 · 2023: 319 · 2022: 373 · 2021: 390 · 2020: 400 · 2019: 425 · 2018: 414 · 2017: 419 · 2016: 458 · 2015: 479 · 2014: 519 · 2013: 498 · 2012: 526
- FWCI
- 75.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Keywords
- diabetes complications, diabetic microangiopathy, hyperglycemia, superoxide, mitochondrial electron transport chain, atherosclerosis, diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, oxidative stress, drug discovery
- MeSH terms
- Diabetes Mellitus, Diabetic Angiopathies, Forecasting, Hexosamines, Humans, Hyperglycemia, Protein Kinase C, Glycation End Products, Advanced, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.